First Header Logo Second Header Logo

Defining the therapeutic efficacy, tolerogenic potential, and genotoxicity of liver-targeted AAV gene therapy for hemophilia A


Collapse Biography 

Collapse Overview 
Collapse sponsor award id
R01HL161290

Collapse Time 
Collapse start date
2022-09-15
Collapse end date
2026-06-30